Aghajanian C, Swisher EM, Okamoto A, Steffensen KD, et al. Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the
primary treatment of serous ovarian cancer - an ancillary data analysis of the
VELIA trial. Gynecol Oncol 2021 Dec 17. pii: S0090-8258(21)01638.
PMID: 34930617